{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-072272","form_type":"8-K","ticker":"SUPN","cik":"0001356576","company_name":"SUPERNUS PHARMACEUTICALS, INC.","filed_at":"2024-06-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.073727+00:00","generated_at":"2026-06-01T04:04:14.293656+00:00","sec_items":["5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Supernus annual meeting results: directors elected, equity plan increase approved","bullets":["Class III directors Georges Gemayel and Bethany Sensenig elected with ~48.4M and ~48.6M votes for, respectively.","Say-on-pay proposal approved with 48.2M for, 2.3M against, 1.9M broker non-votes.","Ratification of KPMG as auditor passed with 52.2M for, 272.9K against; no broker non-votes.","Amendment to 2021 Equity Incentive Plan to increase shares passed with 45.5M for, 5.0M against, 1.9M broker non-votes."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-072272","json":"https://secwatch.observer/filing/0001104659-24-072272.json","markdown":"https://secwatch.observer/filing/0001104659-24-072272.md","text":"https://secwatch.observer/filing/0001104659-24-072272.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1356576/000110465924072272/0001104659-24-072272-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1356576/000110465924072272/tm2417381d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T04:04:14.293656+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}